109 filings
Page 2 of 6
8-K
t90hmxmq26quolt0yn
12 May 23
Landos Biopharma Provides Business Update and Reports First Quarter 2023 Results
8:40am
ARS
0mkc3rc4dlr0
19 Apr 23
Annual report to shareholders
8:05am
PRE 14A
sb3sa1nryqs18zij1vpl
10 Apr 23
Preliminary proxy
4:20pm
S-8
04w74 afc
23 Mar 23
Registration of securities for employees
8:57am
8-K
nhicwu 7c
23 Mar 23
Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2022 Results
8:15am
8-K
ck7o fn9qt4j
10 Mar 23
Other Events
5:23pm
8-K
mqbs80a
28 Feb 23
Asset Purchase and Redemption Agreement
5:20pm
8-K
syfi68
13 Jan 23
Entry into a Material Definitive Agreement
8:35am
8-K
4onf 7minfg
5 Jan 23
Landos Biopharma Provides Comprehensive Update on Clinical Development Plans
7:30am
8-K
metd6
5 Jan 23
Landos Biopharma Announces $16.7 Million Private Placement Financing
7:30am
8-K
5x594ir
16 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:31am
8-K
6v7y7e88dkzzzzzzr9
10 Nov 22
Landos Biopharma Reports Third Quarter 2022 Results and Provides Business Update
8:15am
EFFECT
fzfx3r9w
16 Aug 22
Notice of effectiveness
12:15am
S-3/A
fb4s0tu0d 4j87hchms
11 Aug 22
Shelf registration (amended)
9:06am
8-K
wbg75nf 2u
11 Aug 22
Landos Biopharma Reports Second Quarter 2022 Results and Provides Business Update
8:54am